Interested in Connecting? Please contact: Mandar Shah CEO firstname.lastname@example.org
Message the company or request a 1:1 meeting here.
Prima Innovations has developed a topical muscle relaxant, to relieve the pain, tenderness, limitation of motion, and activities restriction associated with skeletal muscle spasm. Topical application will avoid the side effects often seen with orally administered or injected drugs such as drowsiness, headache, nausea, etc.. Prima’s product is positioned to fill a gap in a multi-billion-dollar pain market.
Currently, Prima has acquired proof-of-principle in animal studies and with some human exposure. The FDA approval process can be either through the drug (IND) or device (IDE) route. Prima is seeking funding to advance this product towards achieving a muscle relaxation claim.